Table of Contents

doi : 10.1016/S0923-7534(25)00175-9

Volume 36, Issue 6, June 2025, Pages i-ii

خرید پکیج و مشاهده آنلاین مقاله

Editorial Board

doi : 10.1016/S0923-7534(25)00176-0

خرید پکیج و مشاهده آنلاین مقاله

Neoadjuvant treatment of HER2-positive breast cancer: has the era of antibody–drug conjugates arrived?

doi : 10.1016/j.annonc.2025.03.022

خرید پکیج و مشاهده آنلاین مقاله

Liquid biopsy in gliomas—are we there yet?

doi : 10.1016/j.annonc.2025.03.017

خرید پکیج و مشاهده آنلاین مقاله

Advancing circulating tumor DNA detection: using whole-genome sequencing to power minimal residual disease monitoring in breast cancer

doi : 10.1016/j.annonc.2025.03.008

خرید پکیج و مشاهده آنلاین مقاله

Challenges and opportunities of emerging mechanisms of resistance to KRASG12C inhibitors

doi : 10.1016/j.annonc.2025.03.009

خرید پکیج و مشاهده آنلاین مقاله

ESMO Precision Oncology Working Group recommendations on the structure and quality indicators for molecular tumour boards in clinical practice

doi : 10.1016/j.annonc.2025.02.009

خرید پکیج و مشاهده آنلاین مقاله

Peripheral T- and natural killer-cell lymphomas: ESMO–EHA Clinical Practice Guideline for diagnosis, treatment and follow-up☆

doi : 10.1016/j.annonc.2025.01.023

خرید پکیج و مشاهده آنلاین مقاله

Redefining clinical trial strategic design to support drug approval in medical oncology

doi : 10.1016/j.annonc.2025.03.005

خرید پکیج و مشاهده آنلاین مقاله

Efficacy and safety of neoadjuvant SHR-A1811 with or without pyrotinib in women with locally advanced or early HER2-positive breast cancer: a randomized, open-label, phase II trial

doi : 10.1016/j.annonc.2025.02.011

خرید پکیج و مشاهده آنلاین مقاله

ctDNA detection in cerebrospinal fluid and plasma and mutational concordance with the primary tumor in a multicenter prospective study of patients with glioma☆

doi : 10.1016/j.annonc.2025.02.005

خرید پکیج و مشاهده آنلاین مقاله

Whole genome sequencing-powered ctDNA sequencing for breast cancer detection

doi : 10.1016/j.annonc.2025.01.021

خرید پکیج و مشاهده آنلاین مقاله

Genomic landscape of clinically acquired resistance alterations in patients treated with KRASG12C inhibitors

doi : 10.1016/j.annonc.2025.01.020

خرید پکیج و مشاهده آنلاین مقاله

Oncologic outcomes of retroperitoneal lymph node dissection following first-line chemotherapy for metastatic non-seminomatous germ-cell tumors

doi : 10.1016/j.annonc.2025.03.002

خرید پکیج و مشاهده آنلاین مقاله

Letter to the Editor—Survival among patients treated with total mesorectal excision or selective watch-and-wait after total neoadjuvant therapy: a pooled analysis of the CAO/ARO/AIO-12 and OPRA randomized phase II trials

doi : 10.1016/j.annonc.2025.03.003

خرید پکیج و مشاهده آنلاین مقاله

Reply to the Letter to the Editor by Perez et al. regarding “Survival among patients treated with total mesorectal excision or selective watch-and-wait after total neoadjuvant therapy: a pooled analysis of the CAO/ARO/AIO-12 and OPRA randomized phase II trials�

doi : 10.1016/j.annonc.2025.03.004

خرید پکیج و مشاهده آنلاین مقاله

Advanced cancer: a robust surrogate of cancer mortality in early detection trials?

doi : 10.1016/j.annonc.2025.03.001

خرید پکیج و مشاهده آنلاین مقاله

Corrigendum to “Genomic and transcriptional heterogeneity of multifocal hepatocellular carcinoma�: [Annals of Oncology 30 (2019):990-997]

doi : 10.1016/j.annonc.2025.03.020

خرید پکیج و مشاهده آنلاین مقاله